Brief: Kyntra Bio Presents New Roxadustat Data On Improvements In Patients With Anemia Due To Lower-Risk Myelodysplastic Syndromes
11/06/2026 21:35
BRIEF-Kyntra Bio Presents New Roxadustat Data On Improvements In Patients With Anemia Due To Lower-Risk Myelodysplastic Syndromes June 11 (Reuters) - Kyntra Bio Inc KYNB.O:
KYNTRA BIO PRESENTS NEW ROXADUSTAT DATA ON IMPROVEMENTS IN TRANSFUSION INDEPENDENCE REGARDLESS OF RING SIDEROBLAST STATUS IN PATIENTS WITH ANEMIA DUE TO LOWER-RISK MYELODYSPLASTIC SYNDROMES
KYNTRA BIO - ROXADUSTAT SHOWS NO NEW SAFETY SIGNALS IN LR-MDS PATIENTS
Source text: ID:nGNX2B46Vy
Further company coverage: KYNB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyntra Bio
See all newsBrief: Kyntra Bio Appoints Andrew E. Singer, Mba To Its Board Of Directors
NASDAQ RESUMED AT 01:28 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:23 PM
Kyntra Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kyntra Bio swings to profit in Q2 on deconsolidation of subsidiary